Shandong Buchang Pharmaceuticals Co., Ltd. (603858.SS) released a profit for its first quarter that Increased, from last year
The company's earnings came in at RMB320.411 million, or RMB0.3045 per share. This compares with RMB307.261 million, or RMB0.2899 per share, last year.
The company's revenue for the period fell 7.4% to RMB2.579 billion from RMB2.784 billion last year.
Shandong Buchang Pharmaceuticals Co., Ltd. earnings at a glance (GAAP) :
-Earnings: RMB320.411 Mln. vs. RMB307.261 Mln. last year.-EPS: RMB0.3045 vs. RMB0.2899 last year.-Revenue: RMB2.579 Bln vs. RMB2.784 Bln last year.
For comments and feedback contact: editorial@rttnews.com
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.